NJOY, an Altria company, announced the submission of a supplemental Premarket Tobacco Product Application to the U.S. Food and Drug Administration to commercialize and market the NJOY ACE 2.0 device. This new device incorporates access restriction technology designed to prevent underage use via Bluetooth connectivity to authenticate the user before unlocking the device. The company also re-submitted PMTAs for Blueberry and Watermelon pod products that work exclusively with the NJOY ACE 2.0 device. “Altria’s Vision is to responsibly lead the transition of adult smokers to a smoke-free future. We’re excited to build on our existing FDA-authorized products. NJOY ACE 2.0 includes critical technology features to prevent underage access to flavored NJOY products, while also responsibly providing flavored options for adult smokers and vapers,” said Shannon Leistra, President & Chief Executive Officer of NJOY.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MO:
- Altria Group put volume heavy and directionally bearish
- Altria Stock (NYSE:MO): Aggressive Buyback Strategy Doesn’t Solve Core Issues
- VDC: Strong and Steady Consumer Staples ETF
- XLP ETF: Invest in Consumer Staples Stocks with Durable Demand
- Biden Administration Pauses Planned Ban of Menthol Cigarettes
Questions or Comments about the article? Write to editor@tipranks.com